{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:02:11Z","timestamp":1785441731407,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.transci.2026.104481","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:38:31Z","timestamp":1782625111000},"page":"104481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic plasma exchange in Alzheimer\u2019s disease: From clinical trial to real-world evidence"],"prefix":"10.1016","volume":"65","author":[{"given":"Bhupendra O.","family":"Khatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104481_bib1","series-title":"WHO Newsroom Fact Sheets","author":"Dementia","year":"2025"},{"key":"10.1016\/j.transci.2026.104481_bib2","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.transci.2026.104481_bib3","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2026.104481_bib4","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer's disease facts and figures. Alzheimers Dement 2024;20:3708\u2013821.","DOI":"10.1002\/alz.13809"},{"key":"10.1016\/j.transci.2026.104481_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","article-title":"Understanding the impact of sex and gender in Alzheimer's disease: a call to action","volume":"14","author":"Nebel","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.transci.2026.104481_bib6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"Hurd","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2026.104481_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41514-024-00136-6","article-title":"Cost of care for Alzheimer's disease and related dementias in the United States: 2016\u20132060","volume":"10","author":"Nandi","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.transci.2026.104481_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","article-title":"Survival after initial diagnosis of Alzheimer disease","volume":"140","author":"Larson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2026.104481_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/gps.3946","article-title":"Survival in dementia and predictors of mortality: a review","volume":"28","author":"Todd","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.transci.2026.104481_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.transci.2026.104481_bib11","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5764-dn-2024-vr01","article-title":"Physiopathological mechanisms underlying Alzheimer's disease: a narrative review","volume":"18","author":"Engelhardt","year":"2024","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.transci.2026.104481_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","article-title":"Updates in Alzheimer's disease: from basic research to diagnosis and therapies","volume":"13","author":"Liu","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.transci.2026.104481_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40035-024-00447-4","article-title":"Cellular senescence in Alzheimer's disease: from physiology to pathology","volume":"13","author":"Zhu","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.transci.2026.104481_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-024-03163-y","article-title":"Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?","volume":"21","author":"Lista","year":"2024","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.transci.2026.104481_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00018-024-05225-z","article-title":"Involvement of the glymphatic\/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions","volume":"81","author":"Yamada","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.transci.2026.104481_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.transci.2026.104481_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.transci.2026.104481_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.transci.2026.104481_bib20","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2026.104481_bib21","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2026.104481_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12883-025-04190-9","article-title":"Sensitivity and specificity of the Montreal cognitive assessment using U.S. National Alzheimer coordinating centre uniform data set: a retrospective analysis of 16,309 participants","volume":"25","author":"Ismail","year":"2025","journal-title":"BMC Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib23","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jamainternmed.2015.2152","article-title":"Cognitive tests to detect dementia: a systematic review and meta-analysis","volume":"175","author":"Tsoi","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.transci.2026.104481_bib24","first-page":"CD010783","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)","volume":"2015","author":"Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transci.2026.104481_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.transci.2026.104481_bib26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.transci.2026.104481_bib27","article-title":"Montreal Cognitive Assessment for the detection of dementia","author":"Davis","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transci.2026.104481_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11682-012-9166-3","article-title":"The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI","volume":"6","author":"Skinner","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.transci.2026.104481_bib29","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.transci.2026.104481_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2026.104481_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2026.104481_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.transci.2026.104481_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2026.104481_bib38","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.49.3.786","article-title":"Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease","volume":"49","author":"Jack","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2026.104481_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2026.104481_bib40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.transci.2026.104481_bib41","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2026.104481_bib42","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.transci.2026.104481_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","article-title":"Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: study design and progress","volume":"5","author":"Boada","year":"2019","journal-title":"Alzheimers Dement (N Y"},{"key":"10.1016\/j.transci.2026.104481_bib44","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/alz.12137","article-title":"A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: primary results of the AMBAR study","volume":"16","author":"Boada","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.transci.2026.104481_bib45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3233\/JAD-180243","article-title":"Increased albumin oxidation in cerebrospinal fluid and plasma from Alzheimer's disease patients","volume":"63","author":"Costa","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.transci.2026.104481_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/13872877251375430","article-title":"A real-world study on the safety and efficacy of therapeutic plasma exchange in patients with Alzheimer's disease","volume":"108","author":"Taragano","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.transci.2026.104481_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2026.104481_bib48","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2026.104481_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2026.104481_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/dnp.2009.22.6.1395256","article-title":"Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization","volume":"22","author":"Boada","year":"2009","journal-title":"Drug N Perspect"},{"key":"10.1016\/j.transci.2026.104481_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jca.22026","article-title":"Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study","volume":"38","author":"Boada","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2026.104481_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2026.104481_bib53","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transci.2026.104481_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251401510","article-title":"Shaping the role of plasma exchange in autoimmune neurology: lessons learned from 67 years and over 90,000 procedures","volume":"18","author":"Khatri","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.transci.2026.104481_bib55","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.transci.2026.104481_bib56","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1074\/jbc.270.13.7563","article-title":"Characterization of apolipoprotein J-Alzheimer's A beta interaction","volume":"270","author":"Matsubara","year":"1995","journal-title":"J Biol Chem"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:32:04Z","timestamp":1785439924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1473050226001138"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104481","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange in Alzheimer\u2019s disease: From clinical trial to real-world evidence","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104481"}}